10
Participants
Start Date
May 31, 2007
Primary Completion Date
June 30, 2011
Study Completion Date
June 30, 2011
Rituximab
Rituximab 1000 mg. I.V.on each days 1 and 15 with repeat dosing at 6 months.
Mayo Clinic, Rochester
Brigham and Women's Hospital, Boston
Lead Sponsor
Collaborators (1)
Genentech, Inc.
INDUSTRY
National Center for Research Resources (NCRR)
NIH
Eric Matteson
OTHER